⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procysteine SCHEMBL83023 | 1.00 | — | — | |
| Procysteine SCHEMBL9139321 | 1.00 | HTT (0.53) | — | |
| Procysteine SCHEMBL1134004 | 1.00 | — | — | |
| Procysteine SCHEMBL10623235 | 0.98 | HTT (0.52) | — | |
| Procysteine SCHEMBL4164380 | 0.98 | HTT (0.52) | — | |
| Procysteine SCHEMBL8428864 | 0.98 | HTT (0.52) | — | |
| Procysteine SCHEMBL1150486 | 0.84 | HTT (0.45) | — | |
| Procysteine SCHEMBL20822405 | 0.84 | HTT (0.45) | — | |
| Procysteine SCHEMBL8040939 | 0.83 | HTT (0.41) | — | |
| Procysteine SCHEMBL1681501 | 0.80 | PTGS1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2311 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116011696-B | System and method for quickly adjusting and generating plan scheduling scheme | SHANGHAI SPACEFLIGHT PRECISION MACHINERY INSTITUTE (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12341912-B2 | Method for confirming ownership of digital assets based on hash algorithm and method for tracing to a source of digital assets based on hash algorithm | NANJING UNIVERSITY (CN) | 2025-06-24 | — | — | US | claimed |
| CN-118784243-B | Light quantum digital signature and quantum digital signcryption method | 矩阵时光数字科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-116192409-B | Digital asset issuing method and system | 矩阵时光数字科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-115277019-B | Agile digital signature verification method and system | 矩阵时光数字科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-115378611-B | Quantum security digital signature verification method and system | 矩阵时光数字科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119276498-A | Quantum security data transmission method based on storage device | 矩阵时光数字科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119214977-A | Scalp oil-control fluffy washing and caring liquid and preparation method thereof | 壤声(上海)生物科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4468884-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-12-04 | — | — | EP | claimed |
| CN-118827062-A | Lightweight quantum digital signature and signcryption method based on transmission content | 矩阵时光数字科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| US-5955450-A | Peritoneal dialysis solutions and methods usable to minimize the injury and adverse physiological effects caused by peritonitis | BAXTER INTERNATIONAL INC. (US) | 1999-09-21 | — | — | US | claimed |
| EP-0931541-A1 | Composition containing a procysteine and polyol combination | L'OREAL (FR) | 1999-07-28 | — | — | EP | claimed |
| WO-1998030255-A9 | LOCALIZED INTRAVASCULAR DELIVERY OF ANTIOXIDANT SUBSTANCES FOR INHIBITION OF RESTENOSIS IN RECANALIZED BLOOD VESSELS | — | 1998-12-23 | — | — | WO | claimed |
| WO-1998044024-A1 | POLYMERS WITH THIOL TERMINAL FUNCTION | L'OREAL (FR) | 1998-10-08 | — | — | WO | claimed |
| EP-0555087-B1 | Peritoneal dialysis solutions containing at least one dipeptide | BAXTER INT (US) | 1998-08-05 | — | — | EP | claimed |
| WO-1998030255-A2 | LOCALIZED INTRAVASCULAR DELIVERY OF ANTIOXIDANT SUBSTANCES FOR INHIBITION OF RESTENOSIS IN RECANALIZED BLOOD VESSELS | LOCALMED, INC. (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0804931-A2 | Peritoneal dialysis solutions and their use to minimize injury to mesothelial cells | BAXTER INTERNATIONAL INC. (US) | 1997-11-05 | — | — | EP | claimed |
| CN-1159447-A | New L-2-ketothiazolidine-4-carboxylic derivate and use for treating skin | OREAL (FR) | 1997-09-17 | — | — | CN | claimed |
| EP-0555087-A1 | Peritoneal dialysis solutions containing at least one dipeptide | BAXTER INTERNATIONAL INC. (US) | 1993-08-11 | — | — | EP | claimed |
| WO-1993014796-A1 | PERITONEAL DIALYSIS COMPOSITION AND METHOD USABLE DURING AND AFTER PERITONITIS | BAXTER INTERNATIONAL, INC. (US) | 1993-08-05 | — | — | WO | claimed |